Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Mecasermin, sold under the brand name Increlex, also known as recombinant human insulin-like growth factor-1 (rhIGF-1), is a recombinant form of human insulin-like growth factor 1 (IGF-I) which is used in the long-term treatment of growth failure and short stature in children with severe primary IGF-I deficiency, for instance due to growth hormone…
The analysis highlights Overview, Related Topics and Entities as prominent areas in the source structure around Mecasermin.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Mecasermin shows recurring relationship patterns in the source. For example, Mecasermin → AU: S4 (Prescription only), CA: ℞-only / Schedule D, US: ℞-only Another extracted example is Mecasermin → Monograph. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
growth severe primary deficiency human insulin-like rhigf-1 half-life hours brand name also factor failure children igf-1 related complex recombinant increlex
TTTA extracted 18 structured relationships around Mecasermin. Examples in this analysis include Mecasermin → AHFS/Drugs.com → Monograph and Mecasermin → ATC code → H01AC03 (WHO). The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Mecasermin | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Mecasermin | ATC code | H01AC03 (WHO) | 1.00 | infobox |
| Mecasermin | CAS Number | 68562-41-4 N | 1.00 | infobox |
| Mecasermin | ChEMBL | ChEMBL1201716 N | 1.00 | infobox |
| Mecasermin | ChemSpider | none | 1.00 | infobox |
| Mecasermin | DrugBank | DB01277 N | 1.00 | infobox |
| Mecasermin | Elimination half-life | 5.8 hours | 1.00 | infobox |
| Mecasermin | Formula | C331H512N94O101S7 | 1.00 | infobox |
| Mecasermin | KEGG | D04870 N | 1.00 | infobox |
| Mecasermin | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Mecasermin | Legal status | CA: ℞-only / Schedule D | 1.00 | infobox |
| Mecasermin | Legal status | US: ℞-only | 1.00 | infobox |
| Mecasermin | Molar mass | 7648.71 g·mol−1 | 1.00 | infobox |
| Mecasermin | Other names | FK-780; Recombinant human insulin-like growth factor-1; rhIGF-1; Somatomedin-1 | 1.00 | infobox |
| Mecasermin | Pregnancy category | AU: B3 | 1.00 | infobox |
| Mecasermin | Routes of administration | Subcutaneous injection | 1.00 | infobox |
| Mecasermin | Trade names | Increlex | 1.00 | infobox |
| Mecasermin | UNII | 7GR9I2683O | 1.00 | infobox |
The concept neighborhoods around Mecasermin bring nearby vocabulary together. In this analysis, examples include Growth, Deficiency and Half-life. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
Bridges highlight paths between different parts of the Mecasermin map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Mecasermin to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Overview, Related Topics & Entities, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Mecasermin · EN edition · Analysis: TopicsToTalkAbout